Comparing weight‐based dosing of tacrolimus XR in obese and non‐obese renal transplant recipients
- 10 November 2021
- journal article
- research article
- Published by Wiley in Clinical Transplantation
- Vol. 36 (2) , e14529
Abstract
The recommended initial weight‐based dose of extended‐release (XR) tacrolimus (Envarsus XR) in kidney transplant recipients (KTR) is 0.14 mg/kg/day. However, no data exist regarding dosing recommendations for obese patients specifically. The aim of this study was to evaluate weight‐based dosing requirements in a cohort of obese KTR who were initiated on de novo tacrolimus XR post‐transplantation. The primary outcome was weight‐based dosing requirements (mg/kg/day) on post‐operative day (POD) 7 and 14. Of the 254 KTR, 81 (31%) were obese. The median therapeutic dose on POD7 was 0.1 versus 0.12 vs. 0.14 mg/kg/day in the BMI > 30 kg/m2, BMI 25–30 kg/m2, and BMI < 25 kg/m2, respectively, (p = .0001). This result was similar on POD14; median therapeutic dose was 0.09 versus 0.11 versus 0.15 mg/kg/day in the BMI > 30 kg/m2, BMI 25–30 kg/m2, and BMI < 25 kg/m2, respectively, (p < .001). Therapeutic dose on POD7 and POD14 based on ideal body was similar in all cohorts (p = .238, p = .923, respectively). This finding was supported by a strong linear relationship between ideal body weight (IBW) and therapeutic dose (r = .929). In both obese and non‐obese KTR, IBW had a stronger correlation with the therapeutic dose for tacrolimus XR.Keywords
This publication has 10 references indexed in Scilit:
- Implications for body weight extremes in solid organ transplantationPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2020
- Obesity in kidney transplantationTransplant International, 2019
- Obesity in Kidney TransplantationCardiology in Review, 2019
- Early Outcomes From de Novo Weight-Based Dosing Compared With Conservative Dosing of Tacrolimus in Kidney Transplant Recipients: A Multisite PerspectiveAnnals of Pharmacotherapy, 2017
- Overweight Kidney Transplant Recipients Are at Risk of Being Overdosed Following Standard Bodyweight-Based Tacrolimus Starting DoseTransplantation Direct, 2017
- Body mass index and outcome in renal transplant recipients: a systematic review and meta-analysisBMC Medicine, 2015
- Mechanisms of Lower Maintenance Dose of Tacrolimus in Obese PatientsDrug Metabolism and Pharmacokinetics, 2014
- Opportunities to Optimize Tacrolimus Therapy in Solid Organ Transplantation: Report of the European Consensus ConferenceTherapeutic Drug Monitoring, 2009
- High Initial Blood Levels of Tacrolimus in Overweight Renal Transplant RecipientsTransplantation Proceedings, 2005
- Clinical Pharmacokinetics and Pharmacodynamics of Tacrolimus in Solid Organ TransplantationClinical Pharmacokinetics, 2004